Making healthcare more accessible, effective and less invasive. That’s the ambition of our guest for today, Castomize. 

Spun off from the Singapore University of Technology and Design in late 2022, the firm aims to do so through the use of medical devices made with advanced manufacturing techniques. 

It has since launched its first device, a series of 4D-printed orthopaedic casts which are more comfortable and convenient for patients. The casts are also easier for doctors to apply and remove, and require less resources for hospitals to deploy. 

The casts have won awards at multiple startup events including the K-Startup Grand Challenge.

As a firm, Castomize was also selected as the first startup in incubator VentureBlick’s super incubator programme. 

It is also working with other incubators and accelerators such as Shinhan Square Bridge Incheon, Singapore Management University’s Business Innovations Generator, the Temasek Launchpad and the SUTD. 

But what is the strategic value of working with these players and how does the Castomize envision its growth trajectory to be like? 

On Under the Radar, The Evening Runway’s finance presenter Chua Tian Tian posed these questions to Abel Teo, CEO, Castomize.